SynthesisFrontiers in oncology2021

Meta-Analysis of HER2-Enriched Subtype Predicting the Pathological Complete Response Within HER2-Positive Breast Cancer in Patients Who Received Neoadjuvant Treatment.

Guoshuang Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.